The Importance of Optimal Thermal Ablation Margins in Colorectal Liver Metastases: A Systematic Review and Meta-Analysis of 21 Studies.

colorectal cancer interventional oncology liver metastases margin systematic review thermal ablation

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
12 Dec 2023
Historique:
received: 11 11 2023
revised: 06 12 2023
accepted: 08 12 2023
medline: 23 12 2023
pubmed: 23 12 2023
entrez: 23 12 2023
Statut: epublish

Résumé

Colorectal cancer (CRC) is the second most common cause of cancer-related deaths in the US. Thermal ablation (TA) can be a comparable alternative to partial hepatectomy for selected cases when eradication of all visible tumor with an ablative margin of greater than 5 mm is achieved. This systematic review and meta-analysis aimed to encapsulate the current clinical evidence concerning the optimal TA margin for local cure in patients with colorectal liver metastases (CLM). MEDLINE, EMBASE, and the CENTRAL databases were systematically searched from inception until 1 May 2023, in accordance with the PRISMA Guidelines. Measure of effect included the risk ratio (RR) with 95% confidence interval (CI) using the random-effects model. Overall, 21 studies were included, comprising 2005 participants and 2873 ablated CLMs. TA with margins less than 5 mm were associated with a 3.6 times higher risk for LTP (n = 21 studies, RR: 3.60; 95% CI: 2.58-5.03; This meta-analysis solidifies that a minimal ablation margin over 5 mm is the minimum critical endpoint required, whereas a minimal margin of at least 10 mm yields optimal local tumor control after TA of CLMs.

Sections du résumé

BACKGROUND BACKGROUND
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths in the US. Thermal ablation (TA) can be a comparable alternative to partial hepatectomy for selected cases when eradication of all visible tumor with an ablative margin of greater than 5 mm is achieved. This systematic review and meta-analysis aimed to encapsulate the current clinical evidence concerning the optimal TA margin for local cure in patients with colorectal liver metastases (CLM).
METHODS METHODS
MEDLINE, EMBASE, and the CENTRAL databases were systematically searched from inception until 1 May 2023, in accordance with the PRISMA Guidelines. Measure of effect included the risk ratio (RR) with 95% confidence interval (CI) using the random-effects model.
RESULTS RESULTS
Overall, 21 studies were included, comprising 2005 participants and 2873 ablated CLMs. TA with margins less than 5 mm were associated with a 3.6 times higher risk for LTP (n = 21 studies, RR: 3.60; 95% CI: 2.58-5.03;
CONCLUSIONS CONCLUSIONS
This meta-analysis solidifies that a minimal ablation margin over 5 mm is the minimum critical endpoint required, whereas a minimal margin of at least 10 mm yields optimal local tumor control after TA of CLMs.

Identifiants

pubmed: 38136351
pii: cancers15245806
doi: 10.3390/cancers15245806
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Auteurs

David-Dimitris Chlorogiannis (DD)

Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA.

Vlasios S Sotirchos (VS)

Weill-Cornell Medical College, Interventional Oncology/Radiology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Christos Georgiades (C)

Department of Vascular and Interventional Radiology, Johns Hopkins University, Baltimore, MD 21287, USA.

Dimitrios Filippiadis (D)

2nd Department of Radiology, University General Hospital "Attikon", Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.

Ronald S Arellano (RS)

Division of Interventional Radiology, Department of Radiology, Massachusetts General Hospital, Boston, MA 02114, USA.

Mithat Gonen (M)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Gregory C Makris (GC)

Department of Vascular and Interventional Radiology, Guy's and St Thomas Hospital, NHS Foundation Trust, London SE1 9RT, UK.

Tushar Garg (T)

Division of Interventional Radiology, Department of Radiology, Massachusetts General Hospital, Boston, MA 02114, USA.

Constantinos T Sofocleous (CT)

Weill-Cornell Medical College, Interventional Oncology/Radiology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Classifications MeSH